# CLCN3

## Overview
The CLCN3 gene encodes the chloride voltage-gated channel 3 (ClC-3), a member of the CLC family of chloride channels, which functions primarily as a chloride/proton exchanger. This protein is categorized as a transmembrane channel and is predominantly localized to intracellular membranes, including endosomes and synaptic vesicles. ClC-3 plays a critical role in maintaining cellular ion homeostasis by facilitating chloride ion transport and contributing to the acidification of intracellular organelles, which is essential for processes such as neurotransmitter loading and release, as well as endosomal trafficking (Poroca2017ClC; Jentsch2018CLC). The protein's structure is characterized by a complex arrangement of α-helices and cystathionine-β-synthase (CBS) domains, which are crucial for its function and regulation (Stauber2012Cell; Jentsch2002Molecular). Disruptions in CLCN3 have been linked to neurodegenerative conditions in animal models, highlighting its importance in cellular physiology and potential clinical significance (Jentsch2018CLC; Yoshikawa2002CLC‐3).

## Structure
The CLCN3 gene encodes a protein that functions as a chloride-proton exchanger, primarily localized to intracellular membranes. The protein is part of the ClC family, characterized by a complex structure with each subunit containing 18 α-helices. These helices are variably tilted and form an internal anti-parallel repeat architecture, which is crucial for the formation of the ion selectivity filter for chloride conductance (Poroca2017ClC; Jentsch2002Molecular). The protein's structure includes three highly conserved chloride-binding sites: an internal site (S_int), a central site (S_cen), and an external site (S_ext) (Poroca2017ClC).

The CLCN3 protein functions as a dimer, with each monomer forming an individual pore, contributing to a double-barreled channel structure (Jentsch2002Molecular). The protein also contains cystathionine-β-synthase (CBS) domains in its cytoplasmic C-terminus, which may influence gating and interact with nucleotides like ATP (Stauber2012Cell; Jentsch2015Discovery). Splice variants of CLCN3, such as ClC-3B, have been identified, which differ in their carboxy-terminal sequences and subcellular localizations (Stauber2012Cell). These structural features are essential for the protein's role in chloride and proton transport.

## Function
The CLCN3 gene encodes the ClC-3 protein, a member of the CLC family of chloride channels, which functions primarily as a chloride/proton exchanger. This protein is involved in the regulation of chloride ion transport across cellular membranes, playing a crucial role in maintaining cellular ion homeostasis and influencing processes such as cell volume regulation and electrical excitability (Poroca2017ClC; Jentsch2018CLC). ClC-3 is predominantly expressed in intracellular compartments, including endosomes and synaptic vesicles, where it contributes to the acidification of these organelles by providing an electrical shunt for the V-type H+-ATPase (Stauber2012Cell; Jentsch2018CLC). This acidification is essential for vesicular functions such as neurotransmitter loading and release, as well as endosomal trafficking (Poroca2017ClC; Jentsch2005PHYSIOLOGICAL).

In neurons, ClC-3 is implicated in synaptic vesicle acidification, which is critical for proper neurotransmission. The protein's activity is regulated by CaMKII-dependent phosphorylation, which modulates its chloride conductance (Huang2001Regulation). ClC-3's role in maintaining ion homeostasis and vesicular function underscores its importance in cellular physiology and organismal health.

## Clinical Significance
Mutations and disruptions in the CLCN3 gene, which encodes the ClC-3 chloride channel, have been associated with several neurodegenerative conditions. In mouse models, the disruption of Clcn3 leads to severe neurodegeneration, including the absence of the hippocampus and early blindness, as well as signs of lysosomal storage disease similar to neuronal ceroid lipofuscinosis (NCL) (Jentsch2018CLC; Yoshikawa2002CLC‐3). These mice also exhibit elevated endosomal pH, suggesting a disruption in cellular protein degradation machinery, which contributes to neurodegeneration (Yoshikawa2002CLC‐3).

The ClC-3 protein is implicated in maintaining pH homeostasis in intracellular organelles, and its deficiency can lead to the accumulation of ceroid-lipofuscin-like materials, contributing to the pathogenesis of NCLs (Yoshikawa2002CLC‐3). In addition, ClC-3 deficiency in mice results in neurological impairments such as blindness, reduced muscle performance, and hyperlocomotion, with notable atrophy and cell density reduction in the hippocampus (Yoshikawa2002CLC‐3).

While no direct human pathologies have been conclusively linked to CLCN3 mutations, the severe phenotypes observed in animal models underscore its potential clinical significance in neurodegenerative diseases (Jentsch2018CLC).

## Interactions
The CLCN3 gene encodes the ClC-3 protein, which is involved in various protein interactions. ClC-3 predominantly localizes to intracellular organelles, particularly within the endosomal pathway, and has been shown to colocalize with ClC-4 and ClC-5. Coimmunoprecipitation studies have demonstrated interactions with these proteins, but not with ClC-6 or ClC-7 (Stauber2012Cell). ClC-3 interacts with clathrin, which is involved in its internalization from the plasma membrane, although this interaction does not require the adaptor protein AP-2 (Stauber2012Cell). In neurons, ClC-3 is found in synaptic vesicles, and its transport to synaptic vesicles and small synaptic-like microvesicles in PC12 cells depends on the adaptor protein AP-3 (Stauber2012Cell).

A splice variant of ClC-3, known as ClC-3B, contains a PDZ-binding motif and interacts with the PDZ domains of EBP50/NHERF-1, PDZK1, and the Golgi-localized protein GOPC, which influences its subcellular localization (Stauber2012Cell). The physiological role of ClC-3B remains unclear, but these interactions suggest a role in cellular localization and function.


## References


[1. (Huang2001Regulation) Ping Huang, Jie Liu, Anke Di, Nicole C. Robinson, Mark W. Musch, Marcia A. Kaetzel, and Deborah J. Nelson. Regulation of human clc-3 channels by multifunctional ca2+/calmodulin-dependent protein kinase. Journal of Biological Chemistry, 276(23):20093–20100, January 2001. URL: http://dx.doi.org/10.1074/jbc.m009376200, doi:10.1074/jbc.m009376200. This article has 128 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m009376200)

[2. (Jentsch2018CLC) Thomas J. Jentsch and Michael Pusch. Clc chloride channels and transporters: structure, function, physiology, and disease. Physiological Reviews, 98(3):1493–1590, July 2018. URL: http://dx.doi.org/10.1152/physrev.00047.2017, doi:10.1152/physrev.00047.2017. This article has 308 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00047.2017)

[3. (Yoshikawa2002CLC‐3) Momono Yoshikawa, Shinichi Uchida, Junji Ezaki, Tatemitsu Rai, Atsushi Hayama, Katsuki Kobayashi, Yujiro Kida, Masaki Noda, Masato Koike, Yasuo Uchiyama, Fumiaki Marumo, Eiki Kominami, and Sei Sasaki. Clc‐3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis. Genes to Cells, 7(6):597–605, June 2002. URL: http://dx.doi.org/10.1046/j.1365-2443.2002.00539.x, doi:10.1046/j.1365-2443.2002.00539.x. This article has 121 citations and is from a peer-reviewed journal.](https://doi.org/10.1046/j.1365-2443.2002.00539.x)

[4. (Jentsch2015Discovery) Thomas J. Jentsch. Discovery of clc transport proteins: cloning, structure, function and pathophysiology. The Journal of Physiology, 593(18):4091–4109, August 2015. URL: http://dx.doi.org/10.1113/JP270043, doi:10.1113/jp270043. This article has 121 citations.](https://doi.org/10.1113/JP270043)

[5. (Stauber2012Cell) Tobias Stauber, Stefanie Weinert, and Thomas J. Jentsch. Cell biology and physiology of clc chloride channels and transporters. July 2012. URL: http://dx.doi.org/10.1002/cphy.c110038, doi:10.1002/cphy.c110038. This article has 124 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cphy.c110038)

[6. (Poroca2017ClC) Diogo R. Poroca, Ryan M. Pelis, and Valérie M. Chappe. Clc channels and transporters: structure, physiological functions, and implications in human chloride channelopathies. Frontiers in Pharmacology, March 2017. URL: http://dx.doi.org/10.3389/fphar.2017.00151, doi:10.3389/fphar.2017.00151. This article has 87 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2017.00151)

[7. (Jentsch2005PHYSIOLOGICAL) Thomas J. Jentsch, Mallorie Poët, Jens C. Fuhrmann, and Anselm A. Zdebik. Physiological functions of clc cl−channels gleaned from human genetic disease and mouse models. Annual Review of Physiology, 67(1):779–807, March 2005. URL: http://dx.doi.org/10.1146/annurev.physiol.67.032003.153245, doi:10.1146/annurev.physiol.67.032003.153245. This article has 191 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1146/annurev.physiol.67.032003.153245)

[8. (Jentsch2002Molecular) Thomas J. Jentsch, Valentin Stein, Frank Weinreich, and Anselm A. Zdebik. Molecular structure and physiological function of chloride channels. Physiological Reviews, 82(2):503–568, April 2002. URL: http://dx.doi.org/10.1152/physrev.00029.2001, doi:10.1152/physrev.00029.2001. This article has 995 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00029.2001)